NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
03/03/2026
Voltar para busca
Dado oficial do USPTO
3DµS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 7, 42
Data de depósito
22/02/2024
Data de registro
15/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/07/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
CN
Examinador
LAM, HAI-LY HUYNH
Localização atual
Historical data usage
Descrição da marca
The mark consists of the stylized wording "3DµS".
Titulares e representantes
Titulares
Triastek, Inc.
Representantes
Alex Patel Patel IP, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 7Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Veterinary preparationsveterinary vaccinesgreases for veterinary purposesantibiotics for veterinary purposesbacterial preparations for veterinary purposesveterinary diagnostic reagentsantibodies for veterinary purposesanti-infective products for veterinary use; dietetic foods adapted for medical purposes; sugar for medical purposes; dental resin for temporary bridgescrowns and veneers; pharmaceutical preparations for the treatment of bone diseases; biological tissue cultures for medical purposes; fever blister treatment preparations; dysmenorrhea treatment preparations; pharmaceutical preparations for the central nervous system; oral analgesics; anticoagulants; tumor suppressing agents; pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for inducing erections; stimulants for the central nervous system; pharmaceutical preparations for treating allergies; anti-diabetic pharmaceuticals; calcium channel blockers; medicinal preparations for the mouth to be applied in the form of tablets; pharmaceutical preparations for the prevention and treatment of cancer; niacinamide preparations for the treatment of acne; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating hypoglycemia; antihypertensives; chemotherapeutics; antivirals; anti-infectives; chemico-pharmaceutical preparations for the treatment of canceroncological diseasescardiovascular and cerebrovascular diseasesrespiratory diseasesgenitourinary diseasesneurological diseasesimmune system related diseasesgastrointestinal diseasesmusculoskeletal diseases and endocrine metabolism-related diseases; living cells for medical use; parathyroid hormone preparations; contraceptive preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; hypnotic sedatives; pharmaceutical products for treating respiratory diseases
Classe 7
Machines for the pharmaceutical processing industryprint heads for 3D printers for drugs and vaccine preparationsprint heads for pharmaceutical drug and vaccine printing machinesindustrial robots for conveying of drugs and vaccine preparationspackaging machines for drugs and vaccine preparations; machines for the pharmaceutical processing industryfor producing drug and vaccine capsules and tablets and mixing machines for drugs and vaccines; 3D printers * for pharmaceutical processing industry; * 3D bioprinters * for pharmaceutical processing industry *
Classe 42
Scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research services; testing of pharmaceuticals; research and development services in the field of medicines; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; technical research in the field of pharmaceutical studies; quality testing of pharmaceutical product; advisory services relating to material testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/02/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2026
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
11/02/2026
FIMP
FINAL DISPOSITION PROCESSED
11/02/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/02/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
22/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/10/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
22/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/07/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
25/06/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
15/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/04/2025
PUBO
PUBLISHED FOR OPPOSITION
15/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
25/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
25/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/02/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/02/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
17/01/2025
GNFR
FINAL REFUSAL E-MAILED
17/01/2025
CNFR
FINAL REFUSAL WRITTEN
17/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2024
RFNT
REFUSAL PROCESSED BY IB
08/10/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/09/2024
RFRR
REFUSAL PROCESSED BY MPU
16/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/09/2024
CNRT
NON-FINAL ACTION WRITTEN
13/09/2024
DOCK
ASSIGNED TO EXAMINER
11/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
15/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 3DµS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.